Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for hereditary hemochromatosis: are DNA-based tests the answer?

W Burke1, A L Franks, L A Bradley

  • 1Department of Medicine Box 354765, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA. wburke@u.washington.edu

Molecular Medicine Today
|September 28, 1999
PubMed
Summary

Universal screening for hereditary hemochromatosis (HH) could prevent severe health issues like cirrhosis and diabetes. However, current screening tests are imperfect and do not definitively predict which individuals will develop serious complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel method for thermal noise reduction, enabling measurements of broadband, low-amplitude electron temperature fluctuations using individual radiometer channels.

The Review of scientific instruments·2026
Same author

Design of a correlation reflectometer radiometer diagnostic and measurements of the electron density-temperature cross-phase angle in the H-mode pedestal with small edge localized modes at ASDEX Upgrade.

The Review of scientific instruments·2025
Same author

System-level recommendations for improved wellness for gynecologic oncologists: A Society of Gynecologic Oncology Review.

Gynecologic oncology·2024
Same author

Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation.

Gynecologic oncology·2021
Same author

Invasive ductal breast carcinoma metastasis to the cervix: A case review and clinical correlation.

Gynecologic oncology reports·2020
Same author

Immature teratoma diagnosed and treated during pregnancy and later complicated by growing teratoma syndrome: A case review with clinical considerations.

Gynecologic oncology reports·2020

Area of Science:

  • Medical Genetics
  • Public Health
  • Internal Medicine

Background:

  • Hereditary hemochromatosis (HH) is a genetic disorder characterized by excess iron accumulation.
  • Untreated HH can lead to severe complications including cirrhosis, diabetes, heart failure, and arthritis.
  • Early diagnosis and treatment, typically phlebotomy, can prevent these complications.

Purpose of the Study:

  • To evaluate the potential benefits and limitations of universal screening for hereditary hemochromatosis.
  • To assess the accuracy and implications of current screening methods for HH.

Main Methods:

  • Review of existing literature on hereditary hemochromatosis screening.
  • Analysis of the effectiveness and limitations of current diagnostic and genetic tests for HH.

Related Experiment Videos

Main Results:

  • Universal screening for HH is proposed due to preventable severe health consequences.
  • Current screening tests can identify individuals at increased risk but are imperfect.
  • The exact proportion of at-risk individuals who will develop clinical manifestations remains uncertain.
  • DNA-based tests do not fully resolve the uncertainties surrounding screening outcomes.

Conclusions:

  • While early detection of hereditary hemochromatosis is desirable for preventing complications, imperfect screening tests pose challenges.
  • Further research is needed to refine screening strategies and better predict clinical outcomes in at-risk populations.